1 active not recruiting, 1 approved for marketing. .
Follow Sentynl Therapeutics, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Long Term Follow-up on Menkes Disease Patients Long Term Follow-Up - Menkes Disease | Active not recruiting | Sentynl Therapeutics, Inc. | 50 | 2019-12-01 | 2026-03-02 | |
| Copper Histidinate Treatment for Menkes Disease copper histidinate - Menkes Disease | Approved for marketing | Sentynl Therapeutics, Inc. | 2026-03-02 |
Menkes Kinky Hair Syndrome (2)
United States (2)